HONG KONG, Dec. 30, 2011 /PRNewswire-Asia-FirstCall/ -- Golden Meditech Holdings Limited ("Golden Meditech" or the "Group," - 801.HK; 910801.TW), China's leading integrated healthcare enterprise, today announced that the Group has been repurchasing its shares from the market in the month of December 2011, accumulating a total of 58,104,000 shares in December 2011, equivalent to 2.84% of the Group's total outstanding shares as of today at a weighted average price of HK$0.84 per share.
Mr. KAM Yuen, Chairman and Chief Executive Officer of the Group, commented, "The Group has made significant progress across various business segments that has not been reflected in its weaker share price. To illustrate our strong confidence in the value of the underlying businesses, reciprocate our shareholders, and capitalize on a weaker capitals market, the Group has continued to repurchase it shares from the open market."
About Golden Meditech Holdings Limited
Golden Meditech Holdings Limited is China's leading integrated-healthcare devices and service operator, and the first medical device enterprise that was publicly listed outside of the PRC. Golden Meditech is a first-mover in China, having established dominant positions in medical devices and healthcare services markets over the years, thanks to its strengths in innovation and market expertise and the ability to capture emerging market opportunities. Going forward, the Group will continue to pursue a leading position in China's healthcare industry both through organic growth and strategic expansion.
Investor Relations Department
Golden Meditech Holdings Limited
48/F, Bank of China Tower, 1 Garden Road, Central, Hong Kong
SOURCE Golden Meditech Holdings Limited